# Autologous Probiotics in Patients With Defunctioning Ileostomy Following LAR for Rectal Cancer

> **NCT07366047** · NA · NOT_YET_RECRUITING · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 40 (estimated)

## Conditions studied

- Rectal Cancer
- Gut Microbiomes
- Autologous Probiotic Transplantation
- Defunctioning Ileostomy

## Interventions

- **DIETARY_SUPPLEMENT:** Autologous Probiotics

## Key facts

- **NCT ID:** NCT07366047
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-31
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07366047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07366047, "Autologous Probiotics in Patients With Defunctioning Ileostomy Following LAR for Rectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07366047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*